Dazodalibep
Horizon Therapeutics
[' ofa ']
#eular2023 #op0143 promising therapy. a phase 2 rct of dazodalidep (cd40l-i) in #sjogren showed significantly more patients on daz group met reduction in essdai vs placebo. interesting to see higher hurdle essdai favoured daz group. phase 3 rcts are underway 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏